enoxacin has been researched along with Carcinoma, Hepatocellular in 3 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Z | 2 |
| Li, Y | 1 |
| Ma, X | 2 |
| Cao, B | 1 |
| Peng, T | 2 |
| Sheng, Y | 2 |
| Peng, H | 2 |
| Li, R | 1 |
| Cao, Y | 1 |
| Xi, R | 1 |
| Li, F | 2 |
| Wang, M | 1 |
| Sun, H | 1 |
| Zhang, G | 2 |
| Zhang, H | 1 |
| Hu, K | 2 |
| Xiao, W | 1 |
| Wang, F | 2 |
| He, Y | 1 |
| Wang, T | 1 |
| Yu, J | 1 |
| Li, L | 1 |
| Li, S | 1 |
| Zou, J | 1 |
| Yuan, Y | 1 |
| Zhao, Y | 1 |
| Shi, H | 1 |
| Liu, W | 1 |
| Lu, X | 1 |
| Young, DD | 1 |
| Connelly, CM | 1 |
| Grohmann, C | 1 |
| Deiters, A | 1 |
3 other studies available for enoxacin and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Identification of a Novel TAR RNA-Binding Protein 2 Modulator with Potential Therapeutic Activity against Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Pr | 2021 |
Discovery of a Novel Small-Molecule Inhibitor Disrupting TRBP-Dicer Interaction against Hepatocellular Carcinoma via the Modulation of microRNA Biogenesis.
Topics: Carcinoma, Hepatocellular; Cell Line; DEAD-box RNA Helicases; Humans; Liver Neoplasms; MicroRNAs; Nu | 2022 |
Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.
Topics: Apoptosis; Base Sequence; Carcinoma, Hepatocellular; Enoxacin; HeLa Cells; Hepatitis C; Humans; Live | 2010 |